12:00 AM
 | 
Dec 23, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Conbercept regulatory update

China approved conbercept from Kanghong to treat wet age-related macular degeneration (AMD). Conbercept...

Read the full 44 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >